Evidence mapPaperPMID 28719397Full record

ReviewCurrent opinion in gastroenterology2017

Obesity and pancreatitis.

Biswajit Khatua, Bara El-Kurdi, Vijay P Singh

Registry-linked trialAbstract readReview
In one paragraph

Review in Current opinion in gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04901949 (Comparison of the Severity and Complications of Acute Pancreatitis in Obese and Non-obese Patients According to the Atlanta and Balthazar Scores), which is not on this map. Cited by 87 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 2 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04901949 completednot on this mapstarted 2020, after this paper: background citation

Comparison of the Severity and Complications of Acute Pancreatitis in Obese and Non-obese Patients According to the Atlanta and Balthazar Scores

TypeobservationalSponsorBezmialem Vakif UniversityRan2020 to 2021Enrolled1,334ConditionsAcute Pancreatitis, Obesity, Body Weight
3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 2 syntheses or guidelines pooled it, 201 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. The obesity pandemic and its impact on non-communicable disease burden.Pflugers Archiv : European journal of physiology · 2025
    Review
  17. Article
  18. Review
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Biswajit KhatuaDepartment of Medicine, Mayo Clinic, Scottsdale, Arizona, USA.
Bara El-Kurdi
Vijay P Singh
Mayo Clinic in Arizona · US

Funding

Fat in Pancreatitis - a Focus on Hypertriglyceridemic PancreatitisR01DK092460 · NIDDK · MAYO CLINIC ARIZONA · PI Vijay Prem Singh · 2023 to 2023
$480k
NIDDK NIH HHS R01 DK092460NIDDK NIH HHS R01 DK100358
6 · The paper itself

Abstract

purpose of reviewThe obesity pandemic poses a unique set of problems for acute pancreatitis - both by increasing acute pancreatitis incidence, and worsening acute pancreatitis severity. This review explores these associations, underlying mechanisms, and potential therapies. RECENT

findingsWe review how the obesity associated increase in gallstones, surgical, and endoscopic interventions for obesity management, diabetes, and related medications such as incretin-based therapies and hypertriglyceridemia may increase the incidence of acute pancreatitis. The mechanism of how obesity may increase acute pancreatitis severity are discussed with a focus on cytokines, adipokines, damage-associated molecular patterns and unsaturated fatty acid-mediated lipotoxicity. The role of obesity in exacerbating pancreatic necrosis is discussed; focusing on obesity-associated pancreatic steatosis. We also discuss how peripancreatic fat necrosis worsens organ failure independent of pancreatic necrosis. Last, we discuss emerging therapies including choice of intravenous fluids and the use of lipase inhibitors which have shown promise during severe acute pancreatitis. SUMMARY: We discuss how obesity may contribute to increasing acute pancreatitis incidence, the role of lipolytic unsaturated fatty acid release in worsening acute pancreatitis, and potential approaches, including appropriate fluid management and lipase inhibition in improving acute pancreatitis outcomes.

Indexed as

Enzyme InhibitorsFatty Acids, UnsaturatedHumansHypertriglyceridemiaIncretinsLipaseLipolysisObesityPancreatitisSeverity of Illness IndexEnzyme InhibitorsFatty Acids, UnsaturatedIncretinsLipase

Identifiers

PMID28719397
PMCPMC6640854
OpenAlexW2737063873

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.